Michael S. Aberman, VP Strategy and Investor Relat at REGENERON PHARMACEUTICALS INC (REGN), sold 8,334 shares at $184.00 ($1.5M) on 2012-11-30, disclosed to the SEC on 2012-12-03.
Scheduled sale ($1.5M) by VP Strategy and Investor Relat under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $182.20 | 3,333 | $607K | 40.2% |
| 2 | $182.20 | 1,097 | $200K | 13.2% |
| 3 | $180.08 | 3,004 | $541K | 35.8% |
| 4 | $181.59 | 400 | $73K | 4.8% |
| 5 | $182.39 | 200 | $36K | 2.4% |
| 6 | $183.77 | 200 |
| $37K |
| 2.4% |
| 7 | $184.00 | 100 | $18K | 1.2% |
| Total | $181.47 avg | 8,334 | $1.5M | 100% |
| Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |